Viewing Compound With Targets


Compound Report Overview

Compound Name: SALICYLAMIDE
Compound Identifier: 700787
Mol Structure 2D: 700787
Molecular Weight: 137
Formula: C7 H7 N O2
Development Status: US FDA Approved
SMILES: NC(=O)c1ccccc1O
Compound Targets
Compound Gene Gene Type View
SALICYLAMIDE 130580 inhibitor of kappaB kinase beta View
SALICYLAMIDE 206000 inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta View